Autolus Therapeutics (AUTL) EBIT Growth (5y) (2022 - 2025)

Autolus Therapeutics (AUTL) EBIT Growth (5y) (2022 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Autolus Therapeutics 404.53 Mn 103.82 Mn -1.04 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -8.89%
Sep 30, 2025 -10.89%
Jun 30, 2025 -9.13%
Mar 31, 2025 -11.09%
Jun 30, 2024 2.64%
Mar 31, 2024 -5.15%
Dec 31, 2023 -20.47%
Sep 30, 2023 5.70%
Jun 30, 2023 -9.67%
Dec 31, 2022 -5.48%